We’re honored that Drug Hunter has selected RGN6024 as one of its Molecules of the Month for May 2025.

A big thank you to the Texas Medical Center Innovation Factory for hosting our CEO, Richard Austin, on the main stage at the Lunch 'n' Launch event!

JPM Healthcare Week has kicked off! Reglagene's CEO Richard Austin is participating in the Biotech Showcase and BIO Partnering. Reach out if you'd like to discuss our brain penetrant cancer therapy!

2024 has been a big year for Reglagene. We are pleased to have expanded to our new office in Houston, Texas.

We’re thrilled to share that Reglagene was selected to participate in the Brain Tumour Research Novel Therapeutics Accelerator on November 6th in Boston!

With almost 700 attendees at the Texas Life Science forum, it was an honor to have the opportunity to be a presenting company! Many thanks to Ann Tanabe with BioHouston and Brad Burke with Rice Alliance for Technology and Entrepreneurship for putting together a top tier event!

Earlier this month, our CEO, Richard Austin, delivered a powerful pitch at the IC3 Life Science Summit in Dallas, showcasing our mission to redefine brain cancer treatment. A huge thank you to BioNTX for hosting an incredible event and for bringing together visionary leaders in life sciences.

Thank you, Arizona! Last month, Reglagene’s CEO Richard Austin had the privilege of presenting at Arizona BioIndustry Association (AZBio)’s White Hat Conference, and we couldn’t be more grateful.